Humanised monoclonal antibody therapy for rheumatoid arthritis.
Monoclonal antibodies that target T cells have shown some benefit in rheumatoid arthritis although responses have not been long lasting. This is partly due to insufficient therapy consequent upon antibody immunogenicity. Use of humanised antibodies, which are expected to be less foreign to man than...
Những tác giả chính: | Isaacs, J, Watts, R, Hazleman, B, Hale, G, Keogan, M, Cobbold, S, Waldmann, H |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
1992
|
Những quyển sách tương tự
-
HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
Bằng: Isaacs, J, et al.
Được phát hành: (1992) -
Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
Bằng: Isaacs, J, et al.
Được phát hành: (2004) -
Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
Bằng: Isaacs, J, et al.
Được phát hành: (2005) -
Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
Bằng: Isaacs, J, et al.
Được phát hành: (2005) -
Humanized monoclonal antibody treatment in rheumatoid arthritis.
Bằng: Kyle, V, et al.
Được phát hành: (1991)